JP2005517433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005517433A5 JP2005517433A5 JP2003569790A JP2003569790A JP2005517433A5 JP 2005517433 A5 JP2005517433 A5 JP 2005517433A5 JP 2003569790 A JP2003569790 A JP 2003569790A JP 2003569790 A JP2003569790 A JP 2003569790A JP 2005517433 A5 JP2005517433 A5 JP 2005517433A5
- Authority
- JP
- Japan
- Prior art keywords
- sina molecule
- nucleotide
- nucleotides
- fragment
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003729 nucleotide group Chemical group 0.000 claims 23
- 239000002773 nucleotide Substances 0.000 claims 19
- 239000012634 fragment Substances 0.000 claims 14
- 230000000692 anti-sense effect Effects 0.000 claims 13
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 239000002213 purine nucleotide Substances 0.000 claims 5
- 208000035657 Abasia Diseases 0.000 claims 4
- 150000003212 purines Chemical class 0.000 claims 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 3
- 239000002719 pyrimidine nucleotide Substances 0.000 claims 3
- 150000003230 pyrimidines Chemical class 0.000 claims 3
- 108020004635 Complementary DNA Proteins 0.000 claims 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 claims 2
- 108091028664 Ribonucleotide Proteins 0.000 claims 2
- 101150033527 TNF gene Proteins 0.000 claims 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 230000009368 gene silencing by RNA Effects 0.000 claims 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 2
- 239000002336 ribonucleotide Substances 0.000 claims 2
- 125000002652 ribonucleotide group Chemical group 0.000 claims 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims 2
- 102000003390 tumor necrosis factor Human genes 0.000 claims 2
- IQFYYKKMVGJFEH-BIIVOSGPSA-N 2'-deoxythymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-BIIVOSGPSA-N 0.000 claims 1
- 244000089409 Erythrina poeppigiana Species 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 235000009776 Rathbunia alamosensis Nutrition 0.000 claims 1
- 108091081021 Sense strand Proteins 0.000 claims 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35858002P | 2002-02-20 | 2002-02-20 | |
| US36312402P | 2002-03-11 | 2002-03-11 | |
| US38678202P | 2002-06-06 | 2002-06-06 | |
| US40678402P | 2002-08-29 | 2002-08-29 | |
| US40837802P | 2002-09-05 | 2002-09-05 | |
| US40929302P | 2002-09-09 | 2002-09-09 | |
| US42935902P | 2002-11-26 | 2002-11-26 | |
| US44012903P | 2003-01-15 | 2003-01-15 | |
| PCT/US2003/004741 WO2003070897A2 (en) | 2002-02-20 | 2003-02-20 | RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005517433A JP2005517433A (ja) | 2005-06-16 |
| JP2005517433A5 true JP2005517433A5 (enExample) | 2006-03-30 |
Family
ID=27761726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003569790A Pending JP2005517433A (ja) | 2002-02-20 | 2003-02-20 | 短干渉核酸（ｓｉＮＡ）を用いるＴＮＦおよびＴＮＦレセプタースーパーファミリー遺伝子発現のＲＮＡ干渉媒介性阻害 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1478730A4 (enExample) |
| JP (1) | JP2005517433A (enExample) |
| AU (1) | AU2003217550A1 (enExample) |
| CA (1) | CA2477014A1 (enExample) |
| WO (1) | WO2003070897A2 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003533986A (ja) | 2000-05-04 | 2003-11-18 | エイブイアイ バイオファーマ， インコーポレイテッド | スプライス領域アンチセンス組成物および方法 |
| US9657294B2 (en) | 2002-02-20 | 2017-05-23 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| US9839649B2 (en) | 2002-11-14 | 2017-12-12 | Thermo Fisher Scientific Inc. | Methods and compositions for selecting siRNA of improved functionality |
| US9228186B2 (en) | 2002-11-14 | 2016-01-05 | Thermo Fisher Scientific Inc. | Methods and compositions for selecting siRNA of improved functionality |
| US7619081B2 (en) | 2002-11-14 | 2009-11-17 | Dharmacon, Inc. | siRNA targeting coatomer protein complex, subunit beta 2 (COPB2) |
| US7612196B2 (en) | 2002-11-14 | 2009-11-03 | Dharmacon, Inc. | siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) |
| US8198427B1 (en) | 2002-11-14 | 2012-06-12 | Dharmacon, Inc. | SiRNA targeting catenin, beta-1 (CTNNB1) |
| US9719094B2 (en) | 2002-11-14 | 2017-08-01 | Thermo Fisher Scientific Inc. | RNAi targeting SEC61G |
| US7977471B2 (en) | 2002-11-14 | 2011-07-12 | Dharmacon, Inc. | siRNA targeting TNFα |
| WO2006006948A2 (en) | 2002-11-14 | 2006-01-19 | Dharmacon, Inc. | METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY |
| US7635770B2 (en) | 2002-11-14 | 2009-12-22 | Dharmacon, Inc. | siRNA targeting protein kinase N-3 (PKN-3) |
| US9719092B2 (en) | 2002-11-14 | 2017-08-01 | Thermo Fisher Scientific Inc. | RNAi targeting CNTD2 |
| US9771586B2 (en) | 2002-11-14 | 2017-09-26 | Thermo Fisher Scientific Inc. | RNAi targeting ZNF205 |
| US7592442B2 (en) | 2002-11-14 | 2009-09-22 | Dharmacon, Inc. | siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2) |
| US9879266B2 (en) | 2002-11-14 | 2018-01-30 | Thermo Fisher Scientific Inc. | Methods and compositions for selecting siRNA of improved functionality |
| US10011836B2 (en) | 2002-11-14 | 2018-07-03 | Thermo Fisher Scientific Inc. | Methods and compositions for selecting siRNA of improved functionality |
| US7691998B2 (en) | 2002-11-14 | 2010-04-06 | Dharmacon, Inc. | siRNA targeting nucleoporin 62kDa (Nup62) |
| DK2284266T3 (da) | 2002-11-14 | 2014-01-13 | Thermo Fisher Scient Biosciences Inc | sIRNA-MOLEKYLE MOD TP53 |
| US7951935B2 (en) | 2002-11-14 | 2011-05-31 | Dharmacon, Inc. | siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC) |
| US20050191653A1 (en) * | 2003-11-03 | 2005-09-01 | Freier Susan M. | Modulation of SGLT2 expression |
| CA2565685A1 (en) * | 2004-05-04 | 2005-12-15 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| US20060040882A1 (en) * | 2004-05-04 | 2006-02-23 | Lishan Chen | Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| US7605250B2 (en) | 2004-05-12 | 2009-10-20 | Dharmacon, Inc. | siRNA targeting cAMP-specific phosphodiesterase 4D |
| US20060253100A1 (en) | 2004-10-22 | 2006-11-09 | Medtronic, Inc. | Systems and Methods to Treat Pain Locally |
| WO2006104913A2 (en) * | 2005-03-25 | 2006-10-05 | Medtronic, Inc. | USE OF ANTI-TNF OR ANTI-ILl RNAI TO SUPPRESS PRO- INFLAMMATORY CYTOKINE ACTIONS LOCALLY TO TREAT PAIN |
| EP2316967A1 (en) | 2005-06-28 | 2011-05-04 | Medtronic, Inc. | Methods and sequences to preferentially suppress expression of mutated huntingtin gene. |
| JP2009507852A (ja) * | 2005-09-08 | 2009-02-26 | エムディーアールエヌエー，インコーポレイテッド | リボ核酸の細胞への送達用医薬組成物 |
| WO2007056153A2 (en) * | 2005-11-04 | 2007-05-18 | Nastech Pharmaceutical Company Inc. | Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| US7785834B2 (en) | 2005-11-10 | 2010-08-31 | Ercole Biotech, Inc. | Soluble TNF receptors and their use in treatment of disease |
| US8138160B2 (en) * | 2006-08-03 | 2012-03-20 | Warsaw Orthopedic, Inc. | Reagents, methods and systems to suppress pro-inflammatory cytokines |
| WO2008109369A2 (en) * | 2007-03-02 | 2008-09-12 | Mdrna, Inc. | Nucleic acid compounds for inhibiting tnf gene expression and uses thereof |
| AU2007352163A1 (en) * | 2007-05-01 | 2008-11-06 | Ercole Biotech, Inc. | Splice switching oligomers for TNF superfamily receptors and their use in treatment of disease |
| JP5475643B2 (ja) | 2007-05-04 | 2014-04-16 | マリーナ バイオテック，インコーポレイテッド | アミノ酸脂質およびその使用 |
| TW200916117A (en) | 2007-08-03 | 2009-04-16 | Alcon Res Ltd | RNAi-related inhibition of TNF α signaling pathway for treatment of ocular angiogenesis |
| WO2009033027A2 (en) | 2007-09-05 | 2009-03-12 | Medtronic, Inc. | Suppression of scn9a gene expression and/or function for the treatment of pain |
| USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
| EP2349210B1 (en) | 2008-10-16 | 2015-03-18 | Marina Biotech, Inc. | Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| US20100215660A1 (en) | 2009-02-23 | 2010-08-26 | Sarwar Hashmi | Kruppel-like factors and fat regulation |
| US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| JP6106085B2 (ja) | 2010-08-24 | 2017-03-29 | サーナ・セラピューティクス・インコーポレイテッドＳｉｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 内部非核酸スペーサーを含む一本鎖ＲＮＡｉ剤 |
| US9260471B2 (en) | 2010-10-29 | 2016-02-16 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) |
| PL226431B1 (pl) | 2013-08-23 | 2017-07-31 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Cząsteczka miRNA do zastosowania do wytwarzania leku do zmniejszania reakcji zapalnej lub zapobiegania zwiększaniu się reakcji zapalnej organizmu |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994001550A1 (en) * | 1992-07-02 | 1994-01-20 | Hybridon, Inc. | Self-stabilized oligonucleotides as therapeutic agents |
| WO1994010301A1 (en) * | 1992-11-03 | 1994-05-11 | Gene Shears Pty. Limited | TNF-α RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |
| US6506569B1 (en) * | 1997-05-30 | 2003-01-14 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor TR10 |
| US6194151B1 (en) * | 1997-09-26 | 2001-02-27 | Millenium Pharmaceuticals, Inc. | Molecules of the TNF receptor superfamily and uses therefor |
| WO1999027086A1 (en) * | 1997-11-25 | 1999-06-03 | Brax Group Limited | Chimeric antisense oligonucleotides against tnf-alpha and their uses |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| US6007995A (en) * | 1998-06-26 | 1999-12-28 | Isis Pharmaceuticals Inc. | Antisense inhibition of TNFR1 expression |
| DE19956568A1 (de) * | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| RU2322500C2 (ru) * | 2000-12-01 | 2008-04-20 | Макс-Планк-Гезелльшафт Цур Фердерунг Дер Виссеншафтен Е.Ф. | Малые молекулы рнк, опосредующие интерференцию рнк |
-
2003
- 2003-02-20 JP JP2003569790A patent/JP2005517433A/ja active Pending
- 2003-02-20 EP EP03713502A patent/EP1478730A4/en not_active Withdrawn
- 2003-02-20 AU AU2003217550A patent/AU2003217550A1/en not_active Abandoned
- 2003-02-20 CA CA002477014A patent/CA2477014A1/en not_active Abandoned
- 2003-02-20 WO PCT/US2003/004741 patent/WO2003070897A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005517433A5 (enExample) | ||
| JP2005517432A5 (enExample) | ||
| JP2005517438A5 (enExample) | ||
| JP2006502694A5 (enExample) | ||
| JP2005517427A5 (enExample) | ||
| JP2005517430A5 (enExample) | ||
| JP2005517452A5 (enExample) | ||
| JP2005517436A5 (enExample) | ||
| JP2005524393A5 (enExample) | ||
| Hecker et al. | Error analysis of chemically synthesized polynucleotides | |
| CA2457528A1 (en) | Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) | |
| JP2008283975A5 (enExample) | ||
| DE69635744T2 (de) | Modifizierte Nukleinsäuresonden | |
| JP2007529224A5 (enExample) | ||
| JP2013535212A5 (enExample) | ||
| CA2526831A1 (en) | Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina) | |
| JP2009060893A5 (enExample) | ||
| JP2010503382A5 (enExample) | ||
| SI2287305T2 (en) | WITH RNA-INTERFERENCO-DELIVERED INHIBITION OF GEN expression by the use of a small interfering nucleic acid (SIN) | |
| WO2004007718A3 (en) | Rna-interference by single-stranded rna molecules | |
| WO2005121372A3 (en) | Double strand compositions comprising differentially modified strands for use in gene modulation | |
| WO2003040366A3 (fr) | Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene | |
| Pongracz et al. | Oligonucleotide N3′→ P5′ thiophosphoramidates: synthesis and properties | |
| JP2010512747A5 (enExample) | ||
| WO2023201281A3 (en) | Oligonucleotides for atn1 modulation |